Focal Segmental Glomerulosclerosis clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
The purpose of this Phase 2 adaptive study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of PF-06730512 following multiple intravenous infusions in adult subjects with FSGS.
San Francisco, California and other locations